Nature, Vol.523, No.7559, 167-168, 2015
MYELOID DISEASE Another action of a thalidomide derivative
Lenalidomide effectively treats a blood disorder caused by the 5q chromosomal deletion. A study shows that the drug binds to its target, CRBN, to promote the breakdown of an enzyme encoded by a gene in the 5q region. See Article p.183